Efficacy and safety of evogliptin versus sitagliptin as an add-on therapy in Indian patients with type 2 diabetes mellitus inadequately controlled with metformin: A 24-week randomized, double-blind, non-inferiority, EVOLUTION INDIA study

Publication | Closed Access

DOI

Citations

References

2019

Year

Ajay Ajmani, Aparna Agrawal, BRavindra Prasad, Indraneel Basu, Jayashree Shembalkar, Neeraj Manikanth, K Subrahmanyam, Maaya Srinivasa, Manoj Chawla, Manoj Srivastava,

Diabetes Research and Clinical Practice

Metabolic SyndromeIndian PatientsDiabetes ManagementHealth PolicyCardiovascular DiseaseGlobal HealthDiabetesType 2Evolution India StudyDiabetes MellitusPublic HealthInsulin DeliveryMedicine